ClinicalTrials.Veeva

Menu

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Cincinnati Children's Hospital Medical Center logo

Cincinnati Children's Hospital Medical Center

Status

Enrolling

Conditions

Pulmonary; Hypertension
Pulmonary Hypoplasia
Congenital Diaphragmatic Hernia

Treatments

Device: Fetal Tracheal Occlusion

Study type

Interventional

Funder types

Other

Identifiers

NCT02986087
2015-6413

Details and patient eligibility

About

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Full description

Fetuses with congenital diaphragmatic hernia with liver-up, and an observed to expected lung-to-head ratio of <25%, LHR <1, or a moderate category with o/e LHR <30%, singleton pregnancy, no known other anomalies, gestational age < 29 weeks 6 days (severe), gestational age < 31 weeks 6 days (moderate), no maternal disease, maternal age > 18 years old.... meet criteria to be offered fetal tracheal occlusion. We want to test feasibility and efficacy in our center.

Enrollment

40 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Isolated CDH with liver up
  • Severe pulmonary hypoplasia with ultrasound O/E LHR <25% at the time of surgery
  • Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days
  • Moderate pulmonary hypoplasia with ultrasound O/E LHR <30% and liver-up at the time of surgery
  • Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category
  • Maternal age greater than or equal to 18 years
  • Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category
  • Normal karyotype or FISH
  • Normal fetal echocardiogram
  • Singleton pregnancy
  • Willing to remain in the greater Cincinnati area for remainder of pregnancy
  • Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days
  • Family meets psychosocial criteria

Exclusion criteria

  • Patient < 18 years old
  • Multi-fetal pregnancy
  • Rubber latex allergy
  • Preterm labor, cervix shortened (<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa
  • Bilateral CDH, isolated left sided CDH with an O/E > 30%
  • Additional fetal anomaly by ultrasound, MRI, or echocardiogram
  • Chromosomal abnormalities
  • Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy
  • Incompetent cervix with or without a cerclage
  • Placental abnormalities known at time of enrollment
  • Maternal HIV, Hepatits B, Hepatitis C
  • Maternal uterine anomaly
  • No safe or technically feasible fetoscopic approach to balloon placement
  • Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Fetal Tracheal Occlusion
Experimental group
Description:
Fetuses with severe or moderate congenital diaphragmatic hernia will be offered fetal tracheal occlusion to increase lung growth.
Treatment:
Device: Fetal Tracheal Occlusion

Trial contacts and locations

1

Loading...

Central trial contact

Foong-Yen Lim, MD; Jose Peiro, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems